Four years after Bristol-Myers Squibb paid $1.85 billion upfront to make Nektar's bempegaldesleukin a companion drug to its cancer immunotherapy Opdivo, the alliance is being discontinued.

PT101 is an engineered IL-2 mutein fused to a protein backbone, and is vying to come to market along with other IL-2-based therapies, notably Eli Lilly and Nektar Therapeutics’ phase 2 candidate ...

Compared to a classic white tee, a well-made black T-shirt is a wardrobe staple that can punch way above its weight. Much like your favorite black jeans or that go-to little black dress ...

After hours: March 18 at 4:30:11 PM EDT Loading Chart for NKTR ...

After hours: March 21 at 7:59:30 PM EDT Loading Chart for T ...